trial

Integrated Care (IC) Models for Patient-Centered Outcomes

NCTId NCT03451630
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 1,400 (actual)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2022-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
1,400 (actual)
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
None
Start
2018-09-04
Primary completion
2022-11-30
Eligibility
ALL · 21 Years

Interventions & indications

Drugs
High-TouchHigh-TechOptimal Discharge Planning

Sponsors

University of Pittsburgh Medical CenterLead Sponsor
Patient-Centered Outcomes Research InstituteCollaborator

Investigators

1
Dan Swayze, DrPH, MBAPrincipal Investigator

Sites

1 total
Pittsburgh, United States

Facts & assertions

4 sourced
Enrollment
1,400
Phase
NA
Primary Completion Date
2022-11-30
Status
COMPLETED
relationships
The graph out of here
drug
High-Touch
drug
High-Tech
drug
Optimal Discharge Planning
drug
lead_sponsor
University of Pittsburgh Medical Center
company
collaborator
Patient-Centered Outcomes Research Institute
company
indication
Heart Failure
indication
Bipolar Disorder
indication
Schizophrenia
indication
investigator
Dan Swayze, DrPH, MBA
person